SCHEMBL3159980

SCHEMBL3159980

CCOC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CNCCC(=O)OC(C)(C)C)cc1)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.43
NAMPT P43490 3/20 0.43
RXFP1 Q9HBX9 1/20 0.41
SMN1; SMN2 Q16637 5/20 0.41
KMT2A Q03164 6/20 0.38
MEN1 O00255 5/20 0.38
GAA P10253 4/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
SENP1 Q9P0U3 1/20 0.37
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 3/20 0.36
NPSR1 Q6W5P4 3/20 0.36
ABL1 P00519 1/20 0.36
MAPK1 P28482 1/20 0.36
RIN1 Q13671 1/20 0.36
TDP1 Q9NUW8 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2572833 0.93 HIF1A (0.38) MAPTNAMPTKMT2AGAANPC1
SCHEMBL3147765 0.91 LTA4H (0.36) MAPTNAMPTKMT2AMEN1NPC1
SCHEMBL3160809 0.91 OPRM1 (0.36) MAPTNAMPT
SCHEMBL480833 0.90 MAPT (0.44) MAPTNAMPTRXFP1SMN1; SMN2KMT2A
SCHEMBL2569221 0.89 RXFP1 (0.44) MAPTNAMPTRXFP1SMN1; SMN2KMT2A
SCHEMBL479462 0.89 MAPT (0.43) MAPTNAMPTRXFP1SMN1; SMN2KMT2A
SCHEMBL479583 0.89 MAPT (0.48) MAPTNAMPTRXFP1SMN1; SMN2KMT2A
SCHEMBL479587 0.89 MAPT (0.48) MAPTNAMPTRXFP1SMN1; SMN2KMT2A
SCHEMBL479585 0.89 MAPT (0.48) MAPTNAMPTRXFP1SMN1; SMN2KMT2A
SCHEMBL4493463 0.88 FPR2 (0.34) MAPTSMN1; SMN2KMT2AMEN1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2157081-A1 Indolinones substituted in six locations, their manufacture and their application as medicine Boehringer Ingelheim Pharma GmbH & Co. KG (DE) 2010-02-24 EP disclosed
US-6762180-B1 Substituted indolines which inhibit receptor tyrosine kinases BOEHRINGER INGELHEIM PHARMA KG (DE) 2004-07-13 US disclosed